Accumulation of TOX high mobility group box family member 3 promotes the oncogenesis and development of hepatocellular carcinoma through the MAPK signaling pathway

Yufu Peng,Jing Yu,Fei Liu,Leyi Tang,Bo Li,Wei Zhang,Kefei Chen,Haili Zhang,Yonggang Wei,Xuelei Ma,Hubing Shi

DOI: https://doi.org/10.1002/mco2.510

2024-03-11

MedComm

Abstract:The depletion of the tripartite motif containing 56 in hepatocellular carcinoma (HCC) may potentiate the accumulation of TOX high mobility group box family member 3 (TOX3), and further regulate the classical signaling pathways of MAPK and EMT by increasing the expression level of insulin‐like growth factor binding protein 3, eventually promoting the growth and metastasis of HCCs. Microvascular invasion (MVI) has been widely valued in the field of liver surgery because MVI positivity indicates poor prognosis in hepatocellular carcinoma (HCC) patients. However, the potential molecular mechanism underlying the poor prognosis of MVI‐positive HCC patients is unclear. Therefore, this study focused on identifying the key genes leading to poor prognosis in patients with a high degree of malignancy of HCC by examining the molecular signaling pathways in MVI‐positive HCC patients. Through RNA sequencing, TOX high mobility group box family member 3 (TOX3) was demonstrated to be significantly highly expressed in MVI‐positive HCC tissues, which was associated with poor prognosis. The results of in vivo and in vitro showed that TOX3 can promote the oncogenesis and development of HCC by targeting key molecules of the MAPK and EMT signaling pathways. The IP‐MS results indicated that proteasome degradation of TOX3 in HCC cells is potentially mediated by a tripartite motif containing 56 (TRIM56, an E3 ligase) in HCC cells. Inhibiting TRIM56 enhances TOX3 protein levels. Overall, our study identified TOX3 as a key gene in the MAPK and EMT signaling pathways in HCC, and its overexpression confers significant proliferation and invasiveness to tumor cells.